The National Bioethics Advisory Commission Contributing to Public Policy,9780833033642

The National Bioethics Advisory Commission Contributing to Public Policy

by
Edition: 1st
ISBN13: 9780833033642
ISBN10: 0833033646
Format: Paperback
Pub. Date: 2004-01-02
Publisher(s): RAND CORPORATION
List Price: $24.00

Rent Book

Select for Price
Add to Cart
There was a problem. Please try again later.

New Book

We're Sorry
Sold Out

Used Book

We're Sorry
Sold Out

eBook

We're Sorry
Not Available

Buy from our Marketplace starting at $4.18

How Marketplace Works:

  • This item is offered by an independent seller and not shipped from our warehouse
  • Item details like edition and cover design may differ from our description; see seller's comments before ordering.
  • Sellers much confirm and ship within two business days; otherwise, the order will be cancelled and refunded.
  • Marketplace purchases cannot be returned to eCampus.com. Contact the seller directly for inquiries; if no response within two days, contact customer service.
  • Additional shipping costs apply to Marketplace purchases. Review shipping costs at checkout.

Summary

Details goverment, private, and international response to the policy recommendations of the National Bioethics Advisory Commission.

Table of Contents

Preface iii
Tables
xiii
Summary xv
Acknowledgments xxi
Acronyms xxv
Introduction
1(12)
Background on the National Bioethics Advisory Commission
1(1)
The NBAC Reports
2(3)
Response to NBAC's Reports and Recommendations
5(5)
Government Response
8(1)
Response from Professional Societies, Organizations, and Foundations
9(1)
International Response
10(1)
Organization of This Report
10(3)
NBAC in the Public Eye
13(8)
Media Reports That Mention NBAC
13(4)
Publications About NBAC in the Academic Literature
17(4)
Response to the Cloning Human Beings Report
21(22)
Government Response
22(8)
Response from the President of the United States
23(2)
Response from Congress
25(3)
Response from the Department of Energy
28(1)
Response from the Food and Drug Administration
29(1)
Response from State Government (New Jersey)
30(1)
Response from Professional Societies, Organizations, and Foundations
30(7)
Response from the American Association for the Advancement of Science
31(1)
Response from the American Medical Association
32(1)
Response from the American Society for Cell Biology
33(1)
Response from the American Society for Investigative Pathology
33(1)
Response from the Association of American Medical Colleges
33(1)
Response from the Biotechnology Industry Organization
34(2)
Response from the Federation of American Societies for Experimental Biology
36(1)
Response from The Pew Charitable Trusts
36(1)
Response from the United States Conference of Catholic Bishops
37(1)
International Response
37(6)
Response from Australia
38(2)
Response from the United Kingdom
40(1)
Response from the United Nations Educational, Scientific and Cultural Organization
41(2)
Response to the Research Involving Persons with Mental Disorders that May Affect Decisionmaking Capacity Report
43(14)
Government Response
44(9)
Response from the President of the United States
45(1)
Response from Congress (Congressional Testimony)
45(1)
Response from the Department of Health and Human Services
46(1)
Response from the Centers for Disease Control and Prevention (NIOSH)
47(1)
Response from the National Institutes of Health
47(5)
Response from State Government
52(1)
Response from Professional Societies, Organizations, and Foundations
53(2)
Response from the Alzheimer's Association
54(1)
Response from the American Academy of Neurology and American Neurological Association
54(1)
Response from the Association of American Medical Colleges
55(1)
International Response
55(2)
Response to the Research Involving Human Biological Materials: Ethical Issues and Policy Guidance Report
57(14)
Government Response
58(7)
Response from Congress (Legislative Action)
59(1)
Response from the Department of Health and Human Services
60(1)
Response from the Centers for Disease Control and Prevention
60(1)
Response from the Food and Drug Administration
61(1)
Response from the National Institutes of Health
62(2)
Response from the Secretary's Advisory Committee on Genetic Testing
64(1)
Response from State Government (Oregon)
65(1)
Response from Professional Societies, Organizations, and Foundations
65(2)
Response from the Federation of American Societies for Experimental Biology
66(1)
Response from Intermountain Health Care
66(1)
Response from The Online Ethics Center for Engineering and Science
67(1)
International Response
67(4)
Response from the United Kingdom
68(1)
Response from the Organisation for Economic Co-operation and Development
68(1)
Response from Germany
69(1)
Response from Japan
70(1)
Response to the Ethical Issues in Human Stem Cell Research Report
71(32)
Government Response
74(10)
Response from the President of the United States
75(2)
Response from Congress
77(4)
Response from the Department of Health and Human Services
81(1)
Response from the National Institutes of Health
82(2)
Response from Professional Societies, Organizations, and Foundations
84(10)
Response from the American Association for the Advancement of Science and Institute for Civil Society
85(2)
Response from the American Council on Education, Association of American Universities, and National Association of State Universities and Land-Grant Colleges
87(1)
Response from the American Medical Association
88(1)
Response from the American Society for Cell Biology
89(1)
Response from the Association of American Medical Colleges
89(1)
Response from the Biotechnology Industry Organization
90(1)
Response from the Center for Bioethics and Human Dignity
91(1)
Response from the Endocrine Society
91(1)
Response from the Joint Steering Committee for Public Policy
92(1)
Response from the National Academies
92(1)
Response from the Society for Developmental Biology
93(1)
Response from the United States Conference of Catholic Bishops
93(1)
International Response
94(9)
Response from the United Kingdom
94(3)
Response from the European Parliament
97(1)
Response from the European Group on Ethics in Science and New Technologies to the European Commission
97(1)
Response from the International Bioethics Committee of the United Nations Educational, Scientific and Cultural Organization
98(1)
Response from Canada
99(1)
Response from Germany
100(1)
Response from Japan
101(1)
Response from Slovakia
101(2)
Response to the Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries Report
103(10)
Government Response
104(2)
Response from the National Institutes of Health
105(1)
Response from Professional Societies, Organizations, and Foundations
106(3)
Response from the American Association for the Advancement of Science
106(1)
Response from the American Medical Association
107(1)
Response from Public Citizen
108(1)
International Response
109(4)
Response from the United Kingdom
110(1)
Response from the Global Forum for Bioethics in Research
110(3)
Response to the Ethical and Policy Issues in Research Involving Human Participants Report
113(16)
Government Response
116(8)
Response from Congress
117(3)
Response from the Department of Health and Human Services
120(1)
Response from the Centers for Disease Control and Prevention
121(1)
Response from the National Institutes of Health
122(1)
Response from the Veterans Health Administration
123(1)
Response from Professional Societies, Organizations, and Foundations
124(2)
Response from the Alliance for Human Research Protection
124(1)
Response from the American Association for the Advancement of Science
125(1)
Response from the American Medical Association
126(1)
Response from the Association of American Medical Colleges
126(1)
International Response
126(3)
Canada
127(2)
Summary
129(10)
Appendix Data Collection Methods 139(6)
Bibliography 145

An electronic version of this book is available through VitalSource.

This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.

By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.

Digital License

You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.

More details can be found here.

A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.

Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.

Please view the compatibility matrix prior to purchase.